Pall's Q2 profits stable yet Biopharma sales strong
Filtration systems specialist Pall's net profit barely moved in Q2 compared to the similar period last year, up only $400,000 (€331,328) to $32.4m, still its Biopharmaceuticals business, driven by a steady demand in consumables, posted a 4 per cent...